| ²é¿´: 205 | »Ø¸´: 2 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
ÓŰ®µ°°×Ìú³æ (СÓÐÃûÆø)
|
[½»Á÷]
TR-FRET¾ùÏàʱ¼ä·Ö±æÓ«¹â¼¼ÊõÔÀíÓëÓ¦Óà ÒÑÓÐ1È˲ÎÓë
|
||
|
Ò»¡¢ÒýÑÔ ¾ùÏàʱ¼ä·Ö±æÓ«¹â£¨TR-FRET£©¼¼ÊõÊÇÈÚºÏʱ¼ä·Ö±æÓ«¹â£¨TRF£©ºÍÓ«¹â¹²ÕñÄÜÁ¿×ªÒÆ£¨FRET£©Á½´óºËÐļ¼ÊõµÄÐÂÐͼì²âƽ̨£¬ÔÚÒ©Îïɸѡ¡¢ÉúÃü¿ÆÑ§Ñо¿ºÍÁÙ´²Õï¶ÏÁìÓò¾ßÓй㷺ӦÓ᣸ü¼ÊõÎÞÐè·ÖÀëÏ´µÓ²½Ö裬ÔÚÒºÏàÖÐÖ±½ÓÍê³É¼ì²â£¬¼æ¾ß¸ßÁéÃô¶È¡¢¸ßÌØÒìÐÔ¡¢¸ßÖØ¸´ÐÔµÈÓÅÊÆ£¬³ÉΪ¸ßͨÁ¿Ò©ÎïɸѡµÄÀíÏ빤¾ß¡£±¾ÎÄϵͳ²ûÊöTR-FRETµÄ¼¼ÊõÔÀí¡¢ºËÐÄÓÅÊÆ¡¢²Ù×÷Á÷³Ì¼°Ó¦ÓÃÁìÓò¡£ ¶þ¡¢¼¼Êõ·¢Õ¹±³¾° TR-FRET¼¼ÊõÓÉ·¨¹úÑо¿»ú¹¹£¨Cisbio Bioassays£©¿ª·¢²¢ÉÌÒµ»¯Íƹ㣬רΪÉúÃü¿ÆÑ§ºÍÕï¶ÏÁìÓòÌṩ¸ßÖÊÁ¿¼ì²âÊÔ¼ÁºÐ¡£Ó봫ͳµÄÃâÒß·ÖÎö·½·¨Ïà±È£¬¸Ã¼¼ÊõÄܹ»ÎªÊ¹ÓÃÕßÌṩ¸üÁéÃô¡¢¸ü¿É¿¿µÄ¶¨Á¿¼ì²â½á¹û¡£¾¹ý¶àÄê·¢Õ¹£¬TR-FRETÒѽ¨Á¢ÁËÍêÉÆµÄ¼¼ÊõÌåϵ£¬°üÀ¨¾¹ýÑéÖ¤µÄÒ©Îï·¢ÏÖɸѡÊÔ¼Á¡¢¸ßͨÁ¿·ÖÎöÊÔ¼ÁºÐÒÔ¼°ÌåÍâÕï¶ÏÊÔ¼ÁºÐ£¬ÔÚÈ«Çò¿ÆÑк͹¤ÒµÊµÑéÊҵõ½¹ã·ºÓ¦ÓᣠÈý¡¢¼¼ÊõÔÀí TR-FRET¼¼Êõ»ùÓÚʱ¼ä·Ö±æÓ«¹â£¨TRF£©ºÍÓ«¹â¹²ÕñÄÜÁ¿×ªÒÆ£¨FRET£©Á½´óºËÐļ¼Êõ¡£ ʱ¼ä·Ö±æÓ«¹â£¨TRF£©ÀûÓÃÏ¡ÍÁÔªËØÖÐïçÏµÔªËØ£¨ÈçîðEu¡¢ï«Tb£©µÄ¶ÀÌØÓ«¹âÌØÐÔ¡£ÓëÆÕͨӫ¹âÎïÖÊÏà±È£¬ïçÏµÔªËØµÄÓ«¹â°ëË¥ÆÚ³¤´ïºÁÃë¼¶£¬¶øÆÕͨӫ¹âµÄ°ëË¥ÆÚ½öΪÄÉÃë¼¶£¬Á½ÕßÏà²îÁù¸öÊýÁ¿¼¶¡£ÔÚ¼ì²âʱ£¬Í¨¹ýÉèÖÃ50-150΢ÃëµÄʱ¼äÑÓ³Ù£¬ÆÕͨ±³¾°Ó«¹âÐźż¸ºõË¥¼õΪÁ㣬¶øïçÏµÔªËØµÄÓ«¹âÐźÅÈԿɱ»×¼È·¼ì²â¡£ÕâÒ»»úÖÆÏÔÖø½µµÍÁ˱³¾°¸ÉÈÅ£¬Ê¹¼ì²â½á¹ûÕæÊµ·´Ó³ÑùÆ·Çé¿ö¡£ Ó«¹â¹²ÕñÄÜÁ¿×ªÒÆ£¨FRET£©ÀûÓÃÁ½ÖÖÓ«¹â»ùÍÅÖ®¼äµÄÄÜÁ¿´«µÝ¡£ÄÜÁ¿¹©ÌåÊÜÍâÀ´¹âÔ´¼¤·¢ºó£¬Èç¹ûÓëÄÜÁ¿ÊÜÌå×ã¹»½Ó½ü£¨Í¨³£1-10 nm£©£¬¿É½«ÄÜÁ¿¹²Õñ×ªÒÆÖÁÊÜÌ壬ʹÆä·¢³öÌØ¶¨²¨³¤µÄ·¢Éä¹â¡£½«¹©ÌåºÍÊÜÌå·Ö±ð±ê¼ÇÓÚÏ໥×÷ÓõÄÁ½¸öÉúÎï·Ö×ÓÉÏ£¬µ±ÉúÎï·Ö×Ó½áºÏʱ£¬¹©ÌåÓëÊÜÌå±»À½üÖÁÓÐЧ¾àÀ룬²úÉúÄÜÁ¿×ªÒÆÐźš£ÓÉÓÚÊÜÌå·¢Éä¹âÔ´×ÔÄÜÁ¿×ªÒÆ£¬¼ì²âÎÞÐè·ÖÀëδ½áºÏµÄ·Ö×Ó£¬ÊµÏÖÁ˾ùÏà¼ì²â¡£ ËÄ¡¢¼¼ÊõÓÅÊÆ TR-FRET¼¼Êõ×÷ΪÎÞÐèÏ´µÓµÄELISA·½·¨£¬¾ßÓÐÏÔÖøÓÅÊÆ¡£²Ù×÷¼«Îª¼ò±ã£¬²ÉÓÿհåÖ±½Ó¼ÓÑù£¬¼ÓÑùÍê³Éºó½öÐè·õÓý¼´¿É¼ì²â£¬È«³ÌºÄʱԼ2Сʱ¡£ÌåϵÎȶ¨ÐԸߣ¬¼ì²âÐźÅÔÚ7ÌìÄÚ»ù±¾±£³Ö²»±ä£¬ÎªÊµÑé°²ÅÅÌṩÁ˳ä·ÖÁé»îÐÔ¡£ÊʺÏÕä¹óÑù±¾¼ì²â£¬Õû¸öʵÑéÌåϵ½öÐè20΢ÉýÑùÆ·£¬¼«´ó½ÚÔ¼ÁËÑù±¾ÓÃÁ¿¡£ ×÷Ϊ¾ùÏà¼ì²âÌåϵ£¬ÎÞÐè°ü±»ºÍÏ´µÓ²½Ö裬ʡʱʡÁ¦¡£²ÉÓñÈÖµ·¨´¦ÀíÊý¾Ý£¨Èç665nm/620nm£©£¬¿ÉÓÐЧȥ³ý±³¾°Ó«¹â¸ÉÈÅ£¬¼ÙÑôÐÔÂʺͼÙÒõÐÔÂʵ͡£¼ì²â½á¹ûÕæÊµ·´Ó³ÑùƷʵ¼ÊÇé¿ö£¬Äܹ»ÅųýÌìÈ»²úÎï×Ô·¢Ó«¹âÒýÆðµÄ±³¾°¸ÉÈÅ£¬È·±£Êý¾Ý¿Í¹Û¿É¿¿¡£ Îå¡¢²Ù×÷Á÷³Ì TR-FRET¼¼ÊõµÄ²Ù×÷Á÷³Ì¼òµ¥Ã÷ÁË¡£Ê×ÏȽ«ÊµÑéËùÐèÊÔ¼ÁÒÀ´Î¼ÓÈë¼ì²â¿×°å£¬°üÀ¨´ý²âÑùÆ·¡¢±ê¼Ç¹©ÌåµÄ¼ì²â·Ö×Ó¡¢±ê¼ÇÊÜÌåµÄ¼ì²â·Ö×Ó¡£Ëæºó½«·´Ó¦ÌåϵÖÃÓÚÊÊÒËζȷõÓý£¬Ê¹ÉúÎï·Ö×Ó³ä·Ö½áºÏÐγɹ©Ìå-ÊÜÌåÁÚ½ü¸´ºÏÎï¡£·õÓý½áÊøºó£¬Ö±½ÓʹÓüæÈݵļì²âÒÇÆ÷¶Áȡӫ¹âÐźš£Õû¸ö¹ý³ÌÎÞÐèÈκÎÏ´µÓ»ò·ÖÀë²½Ö裬ʵÏÖÁËÕæÕýµÄ¡°¼ÓÑù-·õÓý-¼ì²â¡±Èý²½²Ù×÷£¬¼«´óÌá¸ßÁ˼ì²âЧÂÊ¡£ Áù¡¢¼ì²âÒÇÆ÷ TR-FRET¼¼Êõ¾ßÓÐÁ¼ºÃµÄÒÇÆ÷¼æÈÝÐÔ¡£¾¹ýÑéÖ¤µÄ¼ì²âÒÇÆ÷°üÀ¨¶àÖÖÐͺŵĶ๦ÄÜø±êÒÇ£¨ÈçPerkinElmer EnVision¡¢BMG PheraStar¡¢Tecan InfiniteϵÁеȣ©£¬¾ùÅ䱸ʱ¼ä·Ö±æÓ«¹â¼ì²âÄ£¿é¡£ÕâЩÒÇÆ÷¾¹ýÑϸñ²âÊÔ£¬È·±£ÓëTR-FRETÊÔ¼ÁºÐµÄÍêÃÀÆ¥Åä¡£ÒÇÆ÷¹©Ó¦ÉÌÓë¼¼ÊõÖ§³ÖÍŶӱ£³Ö½ôÃܺÏ×÷£¬ÎªÓû§Ìṩ´ÓÊÔ¼ÁÑ¡Ôñµ½Êý¾Ý·ÖÎöµÄÍêÕû½â¾ö·½°¸¡£ Æß¡¢Ó¦ÓÃÁìÓò TR-FRET¼¼ÊõÔÚ¶à¸öÑо¿ÁìÓò·¢»ÓÖØÒª×÷Óá£ÔÚÒ©Îïɸѡ·½Ã棬¿ÉÓÃÓÚµ°°×-µ°°×Ï໥×÷Óᢼ¤Ã¸»îÐÔ¡¢ÊÜÌåÅäÌå½áºÏµÈ°ÐµãµÄ¸ßͨÁ¿É¸Ñ¡¡£ÔÚÐźÅͨ·Ñо¿ÖУ¬¿É¼ì²âµÚ¶þÐÅʹ·Ö×ÓÈçcAMP¡¢IP1µÄŨ¶È±ä»¯¡£ÔÚ±í¹ÛÒÅ´«Ñ§ÁìÓò£¬ÊÊÓÃÓÚ×éµ°°×ÐÞÊΡ¢DNA¼×»ù»¯µÄ¶¨Á¿·ÖÎö¡£ÔÚÃâÒß¼ì²â·½Ã棬¿ÉÓÃÓÚϸ°ûÒò×Ó¡¢ÉúÎï±êÖ¾ÎïµÄ¾«×¼¶¨Á¿¡£´ËÍ⣬ÔÚPROTAC½µ½â¼ÁÑз¢ÖУ¬TR-FRET¼¼Êõ±»¹ã·ºÓÃÓڰе°°×ÓëE3Á¬½ÓøÏ໥×÷Óõļì²â¡£ °Ë¡¢×ܽáÓëÕ¹Íû TR-FRET¾ùÏàʱ¼ä·Ö±æÓ«¹â¼¼Êõƾ½èÆä¸ßÁéÃô¶È¡¢¸ßÌØÒìÐÔ¡¢²Ù×÷¼ò±ãµÈÓÅÊÆ£¬ÒѳÉΪҩÎïɸѡºÍÉúÃü¿ÆÑ§Ñо¿µÄÖØÒª¹¤¾ß¡£Ëæ×żì²âÒÇÆ÷µÄСÐÍ»¯ºÍÊÔ¼ÁºÐÖÖÀàµÄ²»¶Ï·á¸»£¬¸Ã¼¼Êõ½«ÔÚ´²ÅÔ¿ìËÙ¼ì²â£¨POCT£©ºÍ¾«×¼Ò½ÁÆÁìÓò·¢»Ó¸ü´ó×÷Óá£Î´À´£¬TR-FRET¼¼ÊõÓë΢Á÷¿Ø¡¢×Ô¶¯»¯Æ½Ì¨µÄÈںϣ¬½«½øÒ»²½ÌáÉý¼ì²âͨÁ¿ºÍЧÂÊ£¬ÎªÉúÎïҽѧÑо¿Ìṩ¸üÇ¿ÓÐÁ¦µÄÖ§³Ö¡£ |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©
» ²ÂÄãϲ»¶
292ҩѧµ÷¼Á
ÒѾÓÐ1È˻ظ´
Ò©ÀíѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ118È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
0608104024
ľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 106 (¸ßÖÐÉú)
- ½ð±Ò: 1419.7
- É¢½ð: 200
- ºì»¨: 9
- Ìû×Ó: 1452
- ÔÚÏß: 464.7Сʱ
- ³æºÅ: 646302
- ×¢²á: 2008-11-05
- ÐÔ±ð: GG
- רҵ: ÓлúºÏ³É

3Â¥2026-03-20 22:00:17














»Ø¸´´ËÂ¥
ÓŰ®µ°°×
